Veterinary Medicines

NOBILIS MA5+CLONE 30 LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA PARA POLLOS

Authorised
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Download as PDF

Product identification

Medicine name:
NOBILIS MA5+CLONE 30 LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA PARA POLLOS
Active substance:
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • In drinking water use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Live
    10.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    10.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2906 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/03/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 25/06/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/03/2025
Download